29 Sept 2006
Sunnyvale, Calif., USA & Antwerp, Belgium. IntraOp Medical Corporation
(OTCBB: IOPM), has announced the delivery of its Mobetron radiation
therapy system to St. Augustinius Hospital in Belgium. A fully portable,
self-shielding device, the Mobetron directly delivers intraoperative
electron radiation therapy (IOERT) to patients safely and quickly as
they undergo surgery.
St. Augustinius, which has the first IOERT program in Belgium, will
use Mobetron to treat a variety of tumours, including early-stage breast
cancer. The unit will begin patient treatment in late autumn 2006.
The Mobetron allows radiation and surgical oncologists to pinpoint
the exact area that requires radiation and deliver high doses directly
to the affected tissue during cancer surgery. Hospitals can wheel the
Mobetron between existing operating rooms without the costly renovations
required to accommodate traditional radiation therapy devices. Key
patient benefits of this early and powerful start to radiation therapy
include: increased survival rates, better local tumour control, shorter
treatment cycles, and fewer side effects.
St. Augustinius is a 600-bed hospital located in Antwerp, Belgium
that specializes in treating patients with innovative high-technology
medical equipment. The hospital uses a comprehensive, multidisciplinary
approach to treating cancer, integrating surgery, radiation therapy and
chemotherapy treatments, as appropriate. St. Augustinius treats about
2,500 cancer patients per year.
Donald A. Goer, President and CEO of IntraOp Medical Corporation
said, "Delivering another Mobetron is always exciting, but it is
especially gratifying when that Mobetron provides the first
intraoperative electron radiation therapy program in the country. This
is just further evidence that Mobetron is gaining greater acceptance
worldwide. We look forward to working closely with St. Augustinius and
to providing the most advanced medical technology available to
effectively and efficiently treat cancer."